Overview
You can access the company’s website by clicking here.
Fundamentals
Price
News
-
12 Apr 2018 2 min read
BG-backed Orchard buys GSK rare disease portfolio
BG-backed Orchard buys GSK rare disease portfolio Baillie Gifford-backed gene therapy company Orchard Therapeutics has acquired GlaxoSmithKline’s portfolio of investigational and approved rare disease gene therapies in exchange for a 19.9% equity stake as well as undisclosed milestones and royalties on sales. The acquired product portfolio includes Strimvelis, GSK’s EU-approved gene therapy for children with adenosine deaminase severe […]
-
04 Dec 2015 2 min read
Small Companies Dividend Trust convincingly beats benchmark in H1
Small Companies Dividend Trust has announced its interim results for the six-months ended 31 October 2015. During the period, the NAV per ordinary share rose 11.6% beating the MSCI Small Cap Index, which fell 2.02%. The ordinary share price increased by 17.1% during the period and the discount narrowed from 16.99% to 12.90%. A second […]
